[CYCC] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
05-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -7.41%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 150 0 843 -
PBT -25,915 -22,734 -9,681 -9,125 -8,625 -8,463 -13,774 11.10%
Tax -4,717 -3,847 -1,236 -1,297 -1,337 -993 -1,983 15.53%
NP -21,198 -18,887 -8,445 -7,828 -7,288 -7,470 -11,791 10.26%
Tax Rate - - - - - - - -
Total Cost 21,198 18,887 8,445 7,828 7,438 7,470 12,634 9.00%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 -4,858.67 0.00 -1,398.70 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -32.23 -31.74 -34.86 -143.88 -12.05 -19.58 -68.85 -11.87%
EPS Diluted -32.23 -31.74 -34.86 -143.88 -12.05 -19.58 -68.85 -11.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.